Dimed Distribuidora de Medicamentos (BSP:PNVL3) Equity-to-Asset : 0.37 (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Dimed Distribuidora de Medicamentos Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Dimed Distribuidora de Medicamentos's Total Stockholders Equity for the quarter that ended in Mar. 2024 was R$1,197 Mil. Dimed Distribuidora de Medicamentos's Total Assets for the quarter that ended in Mar. 2024 was R$3,204 Mil. Therefore, Dimed Distribuidora de Medicamentos's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.37.

The historical rank and industry rank for Dimed Distribuidora de Medicamentos's Equity-to-Asset or its related term are showing as below:

BSP:PNVL3' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.34 Med: 0.45 Max: 0.51
Current: 0.37

During the past 13 years, the highest Equity to Asset Ratio of Dimed Distribuidora de Medicamentos was 0.51. The lowest was 0.34. And the median was 0.45.

BSP:PNVL3's Equity-to-Asset is ranked worse than
74.08% of 1088 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs BSP:PNVL3: 0.37

Dimed Distribuidora de Medicamentos Equity-to-Asset Historical Data

The historical data trend for Dimed Distribuidora de Medicamentos's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dimed Distribuidora de Medicamentos Equity-to-Asset Chart

Dimed Distribuidora de Medicamentos Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

Get a 7-Day Free Trial

0.36

0.46

0.44

0.41

0.38

Dimed Distribuidora de Medicamentos Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Equity-to-Asset	Get a 7-Day Free Trial															0.40	0.40	0.39	0.38	0.37

Competitive Comparison of Dimed Distribuidora de Medicamentos's Equity-to-Asset

For the Drug Manufacturers - General subindustry, Dimed Distribuidora de Medicamentos's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dimed Distribuidora de Medicamentos's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dimed Distribuidora de Medicamentos's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Dimed Distribuidora de Medicamentos's Equity-to-Asset falls into.

Dimed Distribuidora de Medicamentos Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Dimed Distribuidora de Medicamentos's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	1173.416	/	3077.47
	=	0.38

Dimed Distribuidora de Medicamentos's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	1196.824	/	3204.298
	=	0.37

Dimed Distribuidora de Medicamentos (BSP:PNVL3) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Dimed Distribuidora de Medicamentos Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Dimed Distribuidora de Medicamentos's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Dimed Distribuidora de Medicamentos (BSP:PNVL3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dimed SA Distribuidora de Medicamentos (BSP:PNVL3) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Avenida Industrial Belgraf, 865, Eldorado do Sul, RS, BRA, 92990-000

Website

https://www.grupopanvel.com.br

Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. Its segments are divided into Retail, Wholesale and Corporate. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. The Wholesale segment is the distributor of drugs in Brazil. The Corporate segment includes Wholesale and Retail, as well as the subsidiary Lifar. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.

Dimed Distribuidora de Medicamentos (BSP:PNVL3) Headlines

No Headlines